Page 7 of 8
Organic & Biomolecular Chemistry
DOI: 10.1039/C5OB01911G
Please do not adjust margins
Journal Name
ARTICLE
6-methyl-2-phenyl-4H-chromen-4-one (4v). Prepared from 6-
2-(3,4-dimethoxyphenyl)-5,7-dimethoxy-4H-chromen-4-one (9).
from 5,7-dimethoxychromanone and 3,4-
methylchromanone and phenylboronic acid pinacol ester using the Prepared
general procedure described above. The residue was purified by dimethoxyphenylboronic acid pinacol ester using the general
silica gel column chromatography (EtOAc : n-Hexane = 1 : 2) to procedure described above. The residue was purified by silica gel
afford 62 mg (85%) of compound 4v as a pale yellow solid; mp 112- column chromatography (EtOAc : n-Hexane = 1 : 2) to afford 62 mg
116 oC;. 1H-NMR (CDCl3, 400 MHz) δ 8.00 (s, 1H), 7.90 (dd, 2H, J = (75%) of compound 914 1H-NMR (CDCl3, 400 MHz) δ 7.49 (dd, 1H, J
.
7.5, 1.7 Hz), 7.54-7.43 (m, 5H), 6.80 (s, 1H), 2.44 (s, 3H); 13C-NMR = 8.5, 2.1 Hz), 7.30 (d, 1H, J = 2.0 Hz), 6.95 (d, 1H, J = 8.6 Hz), 6.60 (s,
(CDCl3, 125 MHz) δ 178.8, 163.5, 154.8, 135.5, 135.3, 132.1, 131.8, 1H), 6.55 (d, 1H, J = 2.2 Hz), 6.36 (d, 1H, J = 2.2 Hz), 3.97 (s, 3H), 3.95
129.2, 129.2, 126.5, 126.5, 125.3, 123.8, 118.1, 107.6, 21.2; LR-MS (s, 6H), 3.92 (s, 3H); 13C-NMR (CDCl3, 125 MHz) δ 177.8, 164.2, 161.1,
(FAB) m/z 237 (M+H+); HR-MS (FAB) calcd for C16H12O2 (M+H+) 160.8, 160.0, 151.9, 149.4, 124.2, 119.7, 111.3, 109.4, 108.8, 108.1,
237.0916; found 237.0914.
96.3, 93.1, 56.6, 56.3, 56.3, 56.0; LR-MS (FAB) m/z 343 (M+H+); HR-
5,7-dimethoxy-2-phenyl-4H-chromen-4-one (4w). Prepared from MS (FAB) calcd for C19H18O6 (M+H+) 343.1182; found 343.1181.
5,7-dimethoxychromanone and phenylboronic acid pinacol ester
using the general procedure described above. The residue was
Acknowledgements
purified by silica gel column chromatography (EtOAc : n-Hexane = 1 :
2) to afford 43 mg (63%) of compound 4w as a white solid; mp 200-
203 oC;. 1H-NMR (CDCl3, 400 MHz) δ 7.88-7.83 (m, 2H), 7.52-7.45 (m,
This research was supported by the Basic Science Research Program
through the National Research Foundation of Korea (NRF), which
was funded by the Ministry of Science, ICT & Future Planning (NRF-
3H), 6.67 (s, 1H), 6.56 (d, 1H, J = 2.3 Hz), 6.36 (d, 1H, J = 2.3 Hz), 3.95
(s, 3H), 3.91 (s, 3H); 13C-NMR (CDCl3, 125 MHz) δ 177.8, 164.3, 161.2,
160.9, 160.2, 131.8, 131.4, 129.2, 129.2, 126.2, 126.2, 109.5, 109.3,
2013R1A1A1062292).
96.4, 93.1, 56.7, 56.0; LR-MS (FAB) m/z 283 (M+H+); HR-MS (FAB)
calcd for C17H14O4 (M+H+) 283.0970; found 283.0970.
6-phenyl-8H-[1,3]dioxolo[4,5-g]chromen-8-one (4x). Prepared
Notes and references
from 6,7-methylenedioxy-chromanone and phenylboronic acid
1.
M. Singh, M. Kaur and O. Silakari, Eur. J. Med. Chem.,
2014, 84, 206.
pinacol ester using the general procedure described above. The
residue was purified by silica gel column chromatography (EtOAc :
n-Hexane = 1 : 2) to afford 50 mg (72%) of compound 4x as a yellow
solid; mp 210-212 oC;. 1H-NMR (CDCl3, 400 MHz) δ 7.90-7.83 (m, 2H),
7.54-7.47 (m, 4H), 6.96 (s, 1H), 6.76 (s, 1H), 6.11 (s, 2H); 13C-NMR
(CDCl3, 125 MHz) δ 177.6, 163.0, 153.8, 153.0, 146.4, 132.0, 131.6,
129.2, 129.2, 126.3, 126.3, 119.2, 107.2, 102.7, 102.6, 98.3; LR-MS
(FAB) m/z 267 (M+H+); HR-MS (FAB) calcd for C16H10O4 (M+H+)
267.0657; found 267.0657.
2.
(a) B. Havsteen, Biochem. Pharmacol., 1983, 32, 1141; (b)
J. A. Manthey, K. Grohmann and N. Guthrie, Curr. Med.
Chem., 2001, 8, 135; (c) D. F. Birt, S. Hendrich and W.
Wang, Pharmacol. Ther., 2001, 90, 157; (d) M. Lopez-
Lazaro, Curr. Med. Chem. Anticancer Agents, 2002, 2, 691;
(e) H. P. Kim, K. H. Son, H. W. Chang and S. S. Kang, J.
Pharmacol. Sci., 2004, 96, 229; (f) S. Chirumbolo, Inflamm.
Allergy Drug Targets, 2010, 9, 263; (g) C. Spatafora and C.
Tringali, Anticancer agents Med. Chem., 2012, 12, 902; (h)
Kumazawa, H. Takimoto, T. Matsumoto and K. Kawaguchi,
Curr. Parm. Des., 2014, 20, 857.
(a) V. N. Kalinin, M. V. Shostakovsky and A. B.
Ponomaryov, Tetrahedron Lett., 1990, 31, 4073; (b) M.
Cushman and D. Nagarathnam, Tetrahedron Lett., 1990,
31, 6497; (c) L. W. Mcgarry and M. R. Detty, J. Org. Chem.,
1990, 55, 4349; (d) P. G. Ciattini, E. Morera, G. Ortar and S.
S. Rossi, Tetrahedron, 1991, 47, 6449; (e) D. C. G. A. Pinto,
A. M. S. Silva and J. A. S. Cavaleiro, Tetrahedron Lett.,
1994, 35, 9459; (f) D. G. Powers, D. S. Casebier, D. Fokas,
W. J. Ryan, J. R. Troth and D. L. Coffen, Tetrahedron, 1998,
54, 4085; (g) D. E. Zembower and H. P. Zhang, J. Org.
Chem., 1998, 63, 9300; (h) H. Miao and Z. Yang, Org. Lett.,
2000, 2, 1765-1768; (i) P. Kumar and M. S. Bodas, Org.
Lett., 2000, 2, 3821; (j) J. A. Seijas, M. P. Vazquez-Tato and
R. Carballido-Reboredo, J. Org. Chem., 2005, 70, 2855; (k)
B. Liang, M. W. Huang, Z. J. You, Z. C. Xiong, K. Lu, R. Fathi,
J. H. Chen and Z. Yang, J. Org. Chem., 2005, 70, 6097; (l) A.
K. Ganguly, S. Kaur, P. K. Mahata, D. Biswas, B. N.
Pramanik and T. M. Chan, Tetrahedron Lett., 2005, 46,
4119; (m) E. Fillion, A. M. Dumas, B. A. Kuropatwa, N. R.
Malhotra and T. C. Sitler, J. Org. Chem., 2006, 71, 409; (n)
B. Kosmrlj and B. Sket, Org. Lett., 2007, 9, 3993; (o) K. H.
Kumar and P. T. Perumal, Tetrahedron, 2007, 63, 9531; (p)
E. Awuah and A. Capretta, Org. Lett., 2009, 11, 3210; (q)
4-oxo-2-phenyl-4H-chromen-7-yl pivalate (4y). Prepared from 4-
oxochroman-7-yl pivalate and phenylboronic acid pinacol ester
using the general procedure described above. The residue was
purified by silica gel column chromatography (EtOAc : n-Hexane = 1 :
2) to afford 34 mg (51%) of compound 4y12 as a pale yellow solid;
mp 129-132oC;. 1H-NMR (CDCl3, 400 MHz) δ 8.25 (d, 1H, J=8.7 Hz),
7.90 (dd, 2H, J=7.5 Hz, J=1.6 Hz), 7.56-7.47 (m, 3H), 7.39 (d, 1H,
J=2.1 Hz), 7.14 (dd, 1H, J=8.7 Hz, J=2.1 Hz), 6.82 (s, 1H), 1.40 (s, 9H);
13C-NMR (CDCl3, 125 MHz) δ 178.0, 176.6, 163.9, 157.0, 155.4,
132.0, 131.8, 129.3, 127.3, 126.5, 121.8, 119.7, 111.3, 107.9, 39.6,
27.3.
3.
5,7-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one
Prepared from 5,7-dimethoxychromanone and
(7).
4-
methoxyphenylboronic acid pinacol ester using the general
procedure described above. The residue was purified by silica gel
column chromatography (EtOAc : n-Hexane = 1 : 2) to afford 65 mg
(87%) of compound 713 1H-NMR (CDCl3, 400 MHz) δ 7.80 (d, 2H, J =
.
8.9 Hz), 6.98 (d, 2H, J = 8.9 Hz), 6.58 (s, 1H), 6.54 (d, 1H, J = 2.3 Hz),
6.35 (d, 1H, J = 2.2 Hz), 3.94 (s, 3H), 3.90 (s, 3H), 3.87 (s, 3H); 13C-
NMR (CDCl3, 125 MHz) δ 177.9, 164.1, 162.3, 161.1, 160.9, 160.0,
127.8, 127.8, 124.0, 114.6, 114.6, 109.4, 107.8, 96.3, 93.0, 56.6,
56.0, 55.7; LR-MS (FAB) m/z 313 (M+H+); HR-MS (FAB) calcd for
C18H16O5 (M+H+) 313.1076; found 313.1073.
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins